Correlation Between Ondine Biomedical and SoftBank Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ondine Biomedical and SoftBank Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ondine Biomedical and SoftBank Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ondine Biomedical and SoftBank Group Corp, you can compare the effects of market volatilities on Ondine Biomedical and SoftBank Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ondine Biomedical with a short position of SoftBank Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ondine Biomedical and SoftBank Group.

Diversification Opportunities for Ondine Biomedical and SoftBank Group

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Ondine and SoftBank is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Ondine Biomedical and SoftBank Group Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SoftBank Group Corp and Ondine Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ondine Biomedical are associated (or correlated) with SoftBank Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SoftBank Group Corp has no effect on the direction of Ondine Biomedical i.e., Ondine Biomedical and SoftBank Group go up and down completely randomly.

Pair Corralation between Ondine Biomedical and SoftBank Group

Assuming the 90 days trading horizon Ondine Biomedical is expected to generate 2.02 times more return on investment than SoftBank Group. However, Ondine Biomedical is 2.02 times more volatile than SoftBank Group Corp. It trades about 0.05 of its potential returns per unit of risk. SoftBank Group Corp is currently generating about 0.05 per unit of risk. If you would invest  700.00  in Ondine Biomedical on September 2, 2024 and sell it today you would earn a total of  75.00  from holding Ondine Biomedical or generate 10.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy65.15%
ValuesDaily Returns

Ondine Biomedical  vs.  SoftBank Group Corp

 Performance 
       Timeline  
Ondine Biomedical 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Ondine Biomedical are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Ondine Biomedical exhibited solid returns over the last few months and may actually be approaching a breakup point.
SoftBank Group Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in SoftBank Group Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, SoftBank Group may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Ondine Biomedical and SoftBank Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ondine Biomedical and SoftBank Group

The main advantage of trading using opposite Ondine Biomedical and SoftBank Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ondine Biomedical position performs unexpectedly, SoftBank Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SoftBank Group will offset losses from the drop in SoftBank Group's long position.
The idea behind Ondine Biomedical and SoftBank Group Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets